Oncology
Conference Coverage
Intensified Temozolomide Fails to Hike Glioblastoma Survival
Major Finding: The primary endpoint of median overall survival was 16.6 months with standard temozolomide vs.
News
Triptorelin Cuts Early Menopause in Breast Cancer
Major Finding: The rate of early menopause was 25.9% for chemotherapy alone, compared with 8.9% for chemotherapy plus triptorelin, and the number...
News
Obesity, Estrogen Status Influence Breast Cancer Outcomes
Major Finding: The risk of death from breast cancer is increased by 69% in obese women, and the risk of death from breast cancer is also increased...
News
Panel Backs Accelerated Approval of Brentuximab for Lymphomas
News
Short-Term ADT with Radiotherapy Ups Prostate Cancer Survival
Major Finding: Adding short-term androgen-deprivation therapy to standard radiotherapy raised overall survival at 10 years from 57% to 62%, cut...
News
Crizotinib Boosts Overall Survival of ALK+ Lung Cancer
Major Finding: Selected patients with ALK-positive, advanced NSCLC treated with crizotinib had a 1-year overall survival rate of 74% and a 2-year...
News
Study: Update Family History Every 5 to 10 Years
Major Finding: The chance that patients’ family histories of colorectal cancer would change substantially between the ages of 30 and 50 years,...
News
Mutation Testing Guided Erlotinib Prescribing in Lung Cancer
Major Finding: Driver mutations were detected in 54% of 516 lung adenocarcinoma tumors.Data Source: Prospective mutational analysis of 1,064...
News
TNF-Alpha Activity Eyed for Role in ‘Chemo Brain’
Major Finding: sTNFRII, a stable measure of TNF-alpha activity, was significantly increased in patients who received chemotherapy as part of their...
News
Endoscopic Resection Sufficient for Many T1 Colorectal Cancers
Major Finding: Assumed risk factors for poor outcomes following discovery of a T1 colorectal cancer on endoscopy – including lymphatic vessel...
News
No Increased Acute Myeloid Leukemia Risk in First-Degree Relatives
Major Finding: First-degree relatives of AML patients did not have an increased risk of developing AML themselves (hazard ratio 0.94).Data Source...